Cargando…
Long-term efficacy and safety of neridronate treatment in patients with complex regional pain syndrome type 1: a pre-specified, open-label, extension study
BACKGROUND: No data on the permanent and curative effect of bisphosphonate treatment in patients with complex regional pain syndrome type-1 (CRPS-1) are currently available. The aim of this pre-specified, open-label, observational study was to evaluate the long-term efficacy and safety of neridronat...
Autores principales: | Varenna, Massimo, Gatti, Davide, Zucchi, Francesca, Crotti, Chiara, Braga, Vania, Iolascon, Giovanni, Frediani, Bruno, Nannipieri, Fabrizio, Rossini, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772942/ https://www.ncbi.nlm.nih.gov/pubmed/36569491 http://dx.doi.org/10.1177/1759720X221142274 |
Ejemplares similares
-
Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study
por: Varenna, Massimo, et al.
Publicado: (2021) -
Clinical development of neridronate: potential for new applications
por: Gatti, Davide, et al.
Publicado: (2013) -
Neridronate for transient osteoporosis of the hip in a child
por: Gaggiano, C., et al.
Publicado: (2022) -
The Rationale for Using Neridronate in Musculoskeletal Disorders: From Metabolic Bone Diseases to Musculoskeletal Pain
por: Iolascon, Giovanni, et al.
Publicado: (2022) -
Recurrent multifocal osteomyelitis (CRMO); effect of neridronate
por: Fontana, Federica, et al.
Publicado: (2014)